These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 656698)

  • 21. Arecoline inhibits catecholamine release from perfused rat adrenal gland.
    Lim DY; Kim IS
    Acta Pharmacol Sin; 2006 Jan; 27(1):71-9. PubMed ID: 16364213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.
    Brindley RL; Bauer MB; Hartley ND; Horning KJ; Currie KPM
    J Neurochem; 2017 Oct; 143(2):171-182. PubMed ID: 28815595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of adrenal paraneurons: substance P and somatostatin as inhibitory modulators of the nicotinic response.
    Mizobe F; Kozousek V; Dean DM; Livett BG
    Brain Res; 1979 Dec; 178(2-3):555-66. PubMed ID: 509217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo demonstration of a paracrine, inhibitory action of Met-enkephalin on adrenomedullary catecholamine release in the rat.
    Jarry H; Dietrich M; Barthel A; Giesler A; Wuttke W
    Endocrinology; 1989 Aug; 125(2):624-9. PubMed ID: 2752969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of secretion of catecholamines from the rat adrenal medulla during continuous exposure to nicotine, muscarine or excess K.
    Malhotra RK; Wakade TD; Wakade AR
    Neuroscience; 1988 Jul; 26(1):313-20. PubMed ID: 3419589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of blockade by flunarizine of bovine adrenal catecholamine release.
    De la Fuente MT; Guantes JM; Del Valle M; Garcia AG
    Eur J Pharmacol; 1992 Dec; 229(2-3):189-96. PubMed ID: 1490523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance P protects against desensitization of the nicotinic response in isolated adrenal chromaffin cells.
    Boksa P; Livett BG
    J Neurochem; 1984 Mar; 42(3):618-27. PubMed ID: 6198467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells.
    Kumakura K; Karoum F; Guidotti A; Costa E
    Nature; 1980 Jan; 283(5746):489-92. PubMed ID: 6243403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choline stimulates nicotinic receptors on adrenal medullary chromaffin cells to induce catecholamine secretion.
    Holz RW; Senter RA
    Science; 1981 Oct; 214(4519):466-8. PubMed ID: 7291988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetrapeptides on N- and C-terminal regions of mastoparan inhibit catecholamine release from chromaffin cells by blocking nicotinic acetylcholine receptor.
    Monoi N; Usui M; Takahashi S; Ito H; Kumakura K; Kasai H
    Cell Mol Neurobiol; 2004 Feb; 24(1):37-50. PubMed ID: 15049509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in tonicity of perfusion medium cause prolonged opening of calcium channels of the rat chromaffin cells to evoke explosive secretion of catecholamines.
    Wakade AR; Malhotra RK; Sharma TR; Wakade TD
    J Neurosci; 1986 Sep; 6(9):2625-34. PubMed ID: 2427669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland.
    Wakade AR
    J Physiol; 1981; 313():463-80. PubMed ID: 7277230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Declining catecholamine secretion in adrenal medulla on prolonged stimulation with acetylcholine.
    Bevington A; Radda GK
    Biochem Pharmacol; 1985 May; 34(9):1497-500. PubMed ID: 3994761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of adrenomedullary catecholamine release by propranolol isomers and clonidine involving mechanisms unrelated to adrenoceptors.
    Orts A; Orellana C; Cantó T; Ceña V; González-García C; García AG
    Br J Pharmacol; 1987 Dec; 92(4):795-801. PubMed ID: 2827826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed nicotinic and muscarinic features of cholinergic receptor coupled to secretion in bovine chromaffin cells.
    Shirvan MH; Pollard HB; Heldman E
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4860-4. PubMed ID: 2052567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of catecholamine release from the adrenal medulla by halothane. Site and mechanism of action.
    Göthert M; Dorn W; Loewenstein I
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):239-49. PubMed ID: 1004635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the release of catecholamines and dopamine-beta-hydroxylase evoked by ouabain in the perfused cat adrenal gland.
    Garcia AG; Hernandez M; Horga JF; Sanchez-Garcia P
    Br J Pharmacol; 1980 Mar; 68(3):571-83. PubMed ID: 6301597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The different effects of D-600 (methoxyverapamil) on the release of adrenal catecholamines induced by acetylcholine, high potassium or sodium deprivation.
    Pinto JE; Trifaró JM
    Br J Pharmacol; 1976 May; 57(1):127-32. PubMed ID: 1276531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of catecholamines and dopamine beta-hydroxylase from the perfused adrenal gland of the cat.
    Dixon WR; Garcia AG; Kirpekar SM
    J Physiol; 1975 Jan; 244(3):805-24. PubMed ID: 1133780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catecholamine release from bovine adrenal medulla in response to maintained depolarization.
    Baker PF; Rink TJ
    J Physiol; 1975 Dec; 253(2):593-620. PubMed ID: 1214228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.